New Oxy's

Discussion in 'Opiates' started by Poohbair, May 21, 2008.

  1. Poohbair

    Poohbair Member

    Messages:
    2
    Likes Received:
    0
    Ok...call me MR. Lucky...but I just got the new Oxys that turn into a gel when water is added to it. Lucky me! Anyhow...I know this is all pretty new since I just read about the FDA talking about these new pills...but is there any word on how to get around this sticky situation?

    Thanks for any info...
     
  2. TooCrisp

    TooCrisp Member

    Messages:
    249
    Likes Received:
    0
    When water is added to it? You shoot them up?
     
  3. Oxyrisin

    Oxyrisin Member

    Messages:
    380
    Likes Received:
    0
    I guess your real lucky cause there isn't any new oxycontins that have come out..Where did you get your source..

    your even more lucky cause you got some old generic pieces of shit''
    So your one lucky bastard haha

    Generic Versions of OxyContin Tablets Withdrawn
    Purdue previously issued a statement that as of February 1, 2008, Teva Pharmaceuticals USA, Inc., IMPAX Laboratories, Inc. and IMPAX’s distributor DAVA Pharmaceuticals, Inc. have ceased distribution and sales of their generic versions of this medication pursuant to the terms of their licensing agreements with Purdue. On December 31, 2006, Endo Pharmaceuticals ceased distribution of its generic version of OxyContin pursuant to its license with Purdue. The licenses granted to Teva, IMPAX and Endo Pharmaceuticals preceded the January 7, 2008 decision of the United States District Court for the Southern District of New York in which the court ruled that Purdue Pharma had not committed inequitable conduct in obtaining its OxyContin patents and that its patents are not unenforceable for that reason. The last of Purdue’s patents on OxyContin Tablets expires April 2013. Purdue expects to be able to meet all demand for long-acting oxycodone prescriptions.
     
  4. Oxyrisin

    Oxyrisin Member

    Messages:
    380
    Likes Received:
    0
    STRAIGHT FROM PURDUE WEBSITE. THEY DON'T HAVE NEW ONES OUT YET THAT ARE TAMPER PROOF

    Stamford, CT - May 5, 2008 – We appreciate the opportunity to participate in today's Joint FDA Advisory Committee meeting.
    We will continue to work with the FDA on our New Drug Application (NDA) for a new formulation of OxyContin® (oxycodone HCl controlled-release) Tablets. Since this new formulation has not been approved by the FDA, we can not make any further statements regarding it or the NDA at this time.

    Untreated and undertreated pain is a serious public health issue in the United States. We remain committed
     
  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice